Visus Therapeutics Patents – Insights & Stats (Updated 2023)

Visus Therapeutics has a total of 68 patents globally, out of which 10 have been granted. Of these 68 patents, more than 66% patents are active. The United States of America is where Visus Therapeutics has filed the maximum number of patents, followed by Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Visus Therapeutics.

Visus Therapeutics was founded in 2019. Visus Therapeutics is a biotech company that develops medications for eye care to enhance people’s vision and offers testing and research services in addition to ocular therapies innovation.

Do read about some of the most popular patents of Visus Therapeutics which have been covered by us in this article and also you can find Visus Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Visus Therapeutics patent portfolio.

How many patents do the Founder and CEO of Visus Therapeutics have?

The Founder and CEO Ben Bergo have 0 patents.

How many patents does Visus Therapeutics have?

Visus Therapeutics has a total of 68 patents globally. These patents belong to 14 unique patent families. Out of 68 patents, 45 patents are active.

How Many Patents did Visus Therapeutics File Every Year?

Visus Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantVisus Therapeutics Applications FiledVisus Therapeutics Patents Granted
20236
20227
2021131
2020123
201921
20184
20168
201533
2013101
201211

How many Visus Therapeutics patents are Alive/Dead?

Worldwide Patents

Visus Therapeutics Patent Portfolio

How Many Patents did Visus Therapeutics File in Different Countries?

Visus Therapeutics Worldwide Patent filing

Countries in which Visus Therapeutics Filed Patents

CountryPatents
United States Of America20
Europe7
Japan5
Australia5
Canada4
Taiwan3
Hong Kong (S.A.R.)3
Mexico2
Italy1
Colombia1
South Africa1
Brazil1
Austria1
New Zealand1
China1
Germany1
Indonesia1
Argentina1
Spain1

Where are Research Centers of Visus Therapeutics Patents Located?

R&S Centres of Visus Therapeutics

10 Best Visus Therapeutics Patents

US8299079B2 is the most popular patent in the Visus Therapeutics portfolio. It has received 62 citations so far from companies like Presbyopia Therapies, Allergan, Lenz Therapeutics.

Below is the list of 10 most cited patents of Visus Therapeutics:

Publication NumberCitation Count
US8299079B262
WO2017044659A141
US8455494B220
US20130310326A114
US20130310327A111
US20130288964A110
US20180250313A15
US20170224771A15
CN108350021A2
WO2020252057A12

What Percentage of Visus Therapeutics US Patent Applications Were Granted?

Visus Therapeutics (Excluding its subsidiaries) has filed 13 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 6 have been granted leading to a grant rate of 50%.

Below are the key stats of Visus Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Visus Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Sterne Kessler Goldstein & Fox Pllc7100%
Brown & Michaels PC50%
Browdy And Neimark Pllc10%

What are Visus Therapeutics key innovation segments?

What Technologies are Covered by Visus Therapeutics?

The chart below distributes patents filed by Visus Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Visus Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Visus Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Visus Therapeutics?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.